skip to primary navigationskip to content

Professor Ludovic Vallier elected to the Fellowship of the Academy of Medical Sciences

last modified May 13, 2020 09:45 AM
The Academy of Medical Sciences has elected 50 of the UK’s most prominent biomedical and health scientists to their Fellowship.

The new Fellows have been chosen for their exceptional contributions to advancing biomedical science via world-leading research discoveries, running national science communication and engagement programmes and translating scientific advances into benefits for patients and the public.

The value of medical science has never been more apparent than during the current coronavirus global health crisis. From testing and vaccine development, to public health and behavioural science, to addressing the impacts of lockdown measures on mental health, biomedical and health scientists are helping to guide the UK through unprecedented challenges.

Professor Ludovic Vallier is respectively Professor of Regenerative Medicine affiliated to the department of Surgery and director of the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre hIPSCs (human induced pluripotent stem cells) core facility. He also recently became co-deputy director of the Cambridge Stem Cell Institute. In parallel, he has been involved in the creation of several biotechnology companies including DefiniGEN and BiliTech.

The Vallier lab study the mechanisms controlling differentiation of pluripotent stem cells into definitive endoderm and during the recent Coronavirus pandemic have refocussed some of the team's research to study the effects of coronavirus on the liver using cholangiocyte organoids which have been developed by the lab.

Read the press release from the Academy of Medical Sciences here.